Stay updated on Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.
Latest updates to the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check67 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.1%
- Check88 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check96 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference1%
- Check110 days agoChange DetectedThe website has been updated from version v2.12.1 to v2.12.2.SummaryDifference0.0%
- Check131 days agoChange DetectedNew entries for Alfasigma S.p.A. and its Study Director have been added, while Galapagos NV and Gilead Sciences have been removed from the list.SummaryDifference0.7%
Stay in the know with updates to Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.